Edit |   |
---|---|
Product Name | Mouse SARS-CoV-2 Omicron Subvariants Total IgG 5-plex Panel (Flow Cytometry Multiplex Bead Assay) |
Description | Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections. |
Size | 96 tests |
Concentration | n/a |
Applications | The kit is developed for qualitative detection of Anti-SARS-CoV-2 Omicron subvariants (BA.1, BA.2, BA.2.12.1, BA.4&BA.5) total IgG antibody in mouse serum. |
Other Names | n/a |
Gene, Accession, CAS # | n/a |
Catalog # | FCM-B07R-96tests |
Price | $1094 |
Order / More Info | Mouse SARS-CoV-2 Omicron Subvariants Total IgG 5-plex Panel (Flow Cytometry Multiplex Bead Assay) from ACROBIOSYSTEMS USA |
Product Specific References | n/a |
China Office:
ACROBIOSYSTEMS China
Room 109, No. 3 Disheng Middle St., BDA,
Beijing, 100176 China
Tel: +86 400-685-2052
Fax: +86 10-5885-0566